Cell and gene therapy player CBM plots expansion, 2,000 new hires with funding from South Korean partner
November 21, 2021
The Center for Breakthrough Medicines (CBM), a CDMO founded in 2019, is getting financial backing from South Korean financial group SK Inc. to expand its manufacturing capacity.
The two companies didn’t disclose a dollar amount, but CBM said it will use the funding to build out its manufacturing suite as well as support operations, research and lab capabilities.
Contact Us Now